Fundz

Onward Therapeutics SA

Epalinges, Vaud, Switzerland · Biotechnology, Health Care, Medical

Onward Therapeutics SA is a clinical stage oncology company focused on developing innovative therapies for cancer treatment. With a commitment to advancing onco-metabolism programs, they aim to identify and develop promising compounds for effective cancer care. The company's research efforts are geared towards translating scientific discoveries into breakthrough therapeutic solutions.

Key facts

Headquarters
Epalinges, Vaud, Switzerland
Employees
10
Industries
Biotechnology, Health Care, Medical
Status
Private
Website
onward-therapeutics.com
LinkedIn
Company page

Recent activity at Onward Therapeutics SA

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Onward Therapeutics SA funding history

DateRoundAmount
Nov 2026Series B$28.0M

Onward Therapeutics SA in the news

Companies similar to Onward Therapeutics SA

  • Swarm Oncology Ltd · Biotechnology, Health Care, Medical, research, Therapeutics
  • Faeth Therapeutics · Biotechnology, Health Care, Medical, research, Therapeutics
  • Aptose Biosciences · Biotechnology, Health Care, Medical, research, Therapeutics
  • Celldex · Biotechnology, Health Care, Medical, research, Therapeutics
  • Genentech · Biotechnology, Health Care, Medical, research, Therapeutics

About Onward Therapeutics SA: questions and answers

What does Onward Therapeutics SA do?

Onward Therapeutics SA is a clinical stage oncology company focused on developing innovative therapies for cancer treatment. With a commitment to advancing onco-metabolism programs, they aim to identify and develop promising compounds for effective cancer care. The company's research efforts are geared towards translating scientific discoveries into breakthrough therapeutic solutions.

Where is Onward Therapeutics SA headquartered?

Onward Therapeutics SA is headquartered in Epalinges, Vaud, Switzerland.

How many employees does Onward Therapeutics SA have?

Onward Therapeutics SA has about 10 employees.

Has Onward Therapeutics SA raised funding?

Yes. Fundz has recorded 1 funding event for Onward Therapeutics SA. The most recent, Series B of $28.0M, was in Nov 2026.

What is the latest news on Onward Therapeutics SA?

On Nov 17, 2026, Onward Therapeutics closes NT$900M (US$28M) Series B financing to advance oncology pipeline. The round includes new investors and supports clinical programs in Taiwan.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Onward Therapeutics SA across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.